Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema.

Cigarette smoke exposure is the major cause of chronic obstructive pulmonary disease (COPD). However, only a minority of smokers develop significant COPD, and patients with asthma or asthma-like airway hyperresponsiveness or eosinophilia experience accelerated loss of lung function after cigarette smoke exposure. Pulmonary inflammation is a characteristic feature of lungs from patients with COPD. Surprisingly, the mediators of this inflammation and their contributions to the pathogenesis and varied natural history of COPD are not well defined. Here we show that IL-13, a critical cytokine in asthma, causes emphysema with enhanced lung volumes and compliance, mucus metaplasia, and inflammation, when inducibly overexpressed in the adult murine lung. MMP-2, -9, -12, -13, and -14 and cathepsins B, S, L, H, and K were induced by IL-13 in this setting. In addition, treatment with MMP or cysteine proteinase antagonists significantly decreased the emphysema and inflammation, but not the mucus in these animals. These studies demonstrate that IL-13 is a potent stimulator of MMP and cathepsin-based proteolytic pathways in the lung. They also demonstrate that IL-13 causes emphysema via a MMP- and cathepsin-dependent mechanism(s) and highlight common mechanisms that may underlie COPD and asthma.

[1]  H. Nagaraja,et al.  Increased Susceptibility to Pulmonary Emphysema among HIV-Seropositive Smokers , 2000, Annals of Internal Medicine.

[2]  S. Rose-John,et al.  The importance of shedding of membrane proteins for cytokine biology. , 2000, European cytokine network.

[3]  B. Rubin,et al.  Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. , 2000, Journal of vascular surgery.

[4]  S. Shapiro,et al.  Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. , 2000, American journal of respiratory cell and molecular biology.

[5]  M. Cosio,et al.  Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. , 1999, American journal of respiratory and critical care medicine.

[6]  L. Fabbri,et al.  CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[7]  H. Boushey.  Glucocorticoid therapy for chronic obstructive pulmonary disease. , 1999, The New England journal of medicine.

[8]  H. Yoon,et al.  Rhinovirus regulation of IL-1 receptor antagonist in vivo and in vitro: a potential mechanism of symptom resolution. , 1999, Journal of immunology.

[9]  K. Brandt,et al.  Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme. , 1999, Arthritis and rheumatism.

[10]  D. Postma,et al.  The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. , 1999, American journal of respiratory and critical care medicine.

[11]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[12]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[13]  R. Clark,et al.  The interrelationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[14]  A. Sousa,et al.  Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[15]  T. Betsuyaku,et al.  Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1998, The European respiratory journal.

[16]  L. Cohn,et al.  IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. , 1998, Journal of immunology.

[17]  Y. Konttinen,et al.  Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[18]  J. Vestbo,et al.  Update on the "Dutch hypothesis" for chronic respiratory disease , 1998, Thorax.

[19]  R. Homer,et al.  Induction of Airway Mucus Production By T Helper 2 (Th2) Cells: A Critical Role For Interleukin 4 In Cell Recruitment But Not Mucus Production , 1997, The Journal of experimental medicine.

[20]  R. Flavell,et al.  Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. , 1997, The Journal of clinical investigation.

[21]  Scott T Weiss,et al.  Airways responsiveness and development and remission of chronic respiratory symptoms in adults , 1997, The Lancet.

[22]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[23]  A. Minty,et al.  The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. , 1997, European cytokine network.

[24]  E. Helm,et al.  Demonstration of the Th1 to Th2 cytokine shift during the course of HIV‐1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry , 1997, AIDS.

[25]  L. O’Driscoll,et al.  Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. , 1997, American journal of respiratory and critical care medicine.

[26]  P. Howarth,et al.  Airway wall remodelling in asthma. , 1997, Thorax.

[27]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[28]  I. Pastan,et al.  Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  N. Hooper,et al.  Membrane protein secretases. , 1997, The Biochemical journal.

[30]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[31]  S. E. Brodie.  New York, New York, USA , 1996 .

[32]  F. Hargreave,et al.  Airway eosinophilia in chronic bronchitis during exacerbations. , 1996, American journal of respiratory and critical care medicine.

[33]  J. Connett,et al.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.

[34]  D. Postma,et al.  Adverse effects of eosinophilia and smoking on the natural history of newly diagnosed chronic bronchitis. , 1995, Chest.

[35]  S. Weiss,et al.  A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: the Normative Aging Study. , 1995, American journal of respiratory and critical care medicine.

[36]  B. Rosner,et al.  Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. , 1995, American journal of respiratory and critical care medicine.

[37]  S. Weiss,et al.  Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Snider,et al.  Pitfalls in antiprotease therapy of emphysema. , 1994, American journal of respiratory and critical care medicine.

[39]  M. Schaefer,et al.  Low Molecular Weight Inhibitors in Corneal Ulceration a , 1994, Annals of the New York Academy of Sciences.

[40]  G. Snider.  Allocation of intensive care. The physician's role. , 1994, American journal of respiratory and critical care medicine.

[41]  P. Ray,et al.  IL-1 and transforming growth factor-beta regulation of fibroblast-derived IL-11. , 1994, Journal of immunology.

[42]  B. Rosner,et al.  Long-term variability of bronchial responsiveness to histamine in a random population sample of adults. , 1993, The American review of respiratory disease.

[43]  S. Kira,et al.  Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers. , 1993, The American review of respiratory disease.

[44]  L. Fabbri,et al.  Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. , 1993, The American review of respiratory disease.

[45]  D. Rich,et al.  Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. , 1992, The Journal of biological chemistry.

[46]  S. Shapiro,et al.  Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.

[47]  D. Postma,et al.  The Dutch hypothesis (chronic non-specific lung disease) revisited. , 1991, The European respiratory journal.

[48]  M. Segal,et al.  The relationship of nonspecific airway responsiveness and atopy to the rate of decline of lung function. The Normative Aging Study. , 1990, The American review of respiratory disease.

[49]  M. Lebowitz,et al.  A reexamination of risk factors for ventilatory impairment. , 1988, The American review of respiratory disease.

[50]  J. Bloom,et al.  The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. , 1987, The New England journal of medicine.

[51]  The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. , 1985, The American review of respiratory disease.

[52]  J. Delaissé,et al.  In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. , 1984, Biochemical and biophysical research communications.

[53]  A. Salminen.  Effects of the protease inhibitor leupeptin on proteolytic activities and regeneration of mouse skeletal muscles after exercise injuries. , 1984, The American journal of pathology.

[54]  A. Fishman.  Pulmonary Diseases and Disorders , 1980 .